Novo Nordisk A/S Logo

Novo Nordisk A/S (NONOF)

OTC

Currency in USD
46.81
+0.48 (+1.04%)

Real-time Data

01:30 PM

Day's Range

46.38
47.46

52 wk Range

34.00
64.75

Recommendations - NONOF - Novo Nordisk A/S

Analyst Ratings - NONOF - Novo Nordisk A/S

Analyst ratings

DateFirmActionRating
Oct 02, 2023Argus ResearchInitiates coverageBuy
Mar 28, 2023BTIGMaintainsBuy
Dec 12, 2022TD CowenMaintainsOutperform
Jun 28, 2022UBSDowngradeNeutral → Sell
Jun 07, 2022JP MorganUpgradeNeutral → Overweight
May 31, 2022GuggenheimUpgradeNeutral → Buy
Mar 16, 2022Deutsche BankUpgradeHold → Buy
Jan 25, 2022LiberumDowngradeHold → Sell
Dec 20, 2021JP MorganDowngradeOverweight → Neutral
Jan 15, 2021Deutsche BankInitiates coverageBuy
Items per row:

Estimates - NONOF - Novo Nordisk A/S

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

Growth estimates

Next 5 years (per year)-132.6%
Past 5 years (per year)-132.6%

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - NONOF - Novo Nordisk A/S

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-07-09-0.04-0.02-0.06‪-150.00%‬
2026-06-11--0.33-0.09+0.24‪-72.73%‬
2026-04-18-0.390.41+0.02‪+5.13%‬
2025-11-20-2.912.98+0.07‪+2.41%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.